Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

American Express Company (AXP) & Last Week’s Worst-Performing Dow Components

Page 1 of 2

As we’re now just days away from the next Federal Reserve meeting, fear, concern, and, most importantly, uncertainty ran rampant this past week on Wall Street, causing the three major indexes to fall lower over the past five trading sessions. The Dow Jones Industrial Average lost 177 points, or 1.16%, and now sits at 15,070, after it briefly dipped below the 15,000 mark this week during intraday trading. The S&P 500 finished the week lower by 1.01%, while the Nasdaq was the big loser, after it declined by 1.31%.

A number of mixed economic data points were released during the week, which didn’t give investors any true indication of whether the economy is any better than it was before the last Fed meeting, or whether the central bank will now begin slowing its stimulus programs.

American Express Company (NYSE:AXP)

Before we hit the Dow losers, for the second consecutive week the index’s biggest winner was Pfizer Inc. (NYSE:PFE). After gaining 3.78% two weeks ago, the stock rose another 3.11% this past week. The main catalyst for the move higher was the announcement that Pfizer Inc. (NYSE:PFE) and Takeda had come to a settlement agreement with Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Sun Pharmaceutical relating to a patent infringement case. The settlement amount came to $2.15 billion, of which Pfizer Inc. (NYSE:PFE) will receive the lion’s shares of and the rest will go to Takeda. This settlement is for more money than both Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Sun made on the sale of their drugs that infringed on the patent, so this should help keep the generic-pharmaceutical companies at bay for some time.

The big losers
The worst-performing Dow component of the week was American Express Company (NYSE:AXP), which lost 5.24% of its value. The stock probably moved lower for a number of reasons this week, including a stock downgrade, a poor initial stock rating from another firm, a weak consumer sentiment number, and rioting in the Middle East. The downgrade came from Barclays, which lowered the rating from “overweight” to “equal weight” but increased the price target from $72 to $82 per share. Oppenheimer also gave the company a less than stellar rating, as it initiated coverage on American Express Company (NYSE:AXP) this week and rated the stock a “perform.” The weak Thomson Reuters/University of Michigan Consumer Sentiment Index may indicate that Americans will cut back on spending and the use of credit, which will have a negative effect on American Express Company (NYSE:AXP) and the other credit card companies. And lastly, the rioting in Turkey this week may hurt American Express Company (NYSE:AXP), as it earns a great deal of revenue from the tourism industry, and with Istanbul being such an important tourist destination, revenues may take a hit.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!